Fresenius Medical Care AG
FMS
$26.35
-$0.49-1.83%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.23B | 20.92B | 20.91B | 20.86B | 21.00B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.23B | 20.92B | 20.91B | 20.86B | 21.00B |
| Cost of Revenue | 15.99B | 15.80B | 15.77B | 15.62B | 15.68B |
| Gross Profit | 5.24B | 5.12B | 5.14B | 5.24B | 5.32B |
| SG&A Expenses | 3.42B | 3.35B | 3.40B | 3.41B | 3.45B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -83.14M | -97.49M | -118.23M | -149.81M | -79.96M |
| Total Operating Expenses | 19.51B | 19.25B | 19.25B | 19.10B | 19.28B |
| Operating Income | 1.72B | 1.67B | 1.67B | 1.76B | 1.72B |
| Income Before Tax | 1.27B | 1.24B | 1.15B | 1.32B | 1.16B |
| Income Tax Expenses | 346.20M | 363.95M | 342.60M | 370.66M | 338.81M |
| Earnings from Continuing Operations | 924.70 | 874.47 | 803.38 | 953.71 | 823.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -204.39M | -208.52M | -219.53M | -238.87M | -251.09M |
| Net Income | 720.31M | 665.95M | 583.85M | 714.85M | 572.46M |
| EBIT | 1.72B | 1.67B | 1.67B | 1.76B | 1.72B |
| EBITDA | 3.14B | 3.09B | 3.10B | 3.22B | 3.20B |
| EPS Basic | 2.45 | 2.27 | 1.99 | 2.44 | 1.95 |
| Normalized Basic EPS | 2.54 | 2.41 | 2.28 | 2.36 | 2.21 |
| EPS Diluted | 2.45 | 2.26 | 1.98 | 2.43 | 1.95 |
| Normalized Diluted EPS | 2.54 | 2.41 | 2.28 | 2.36 | 2.21 |
| Average Basic Shares Outstanding | 1.17B | 1.17B | 1.17B | 1.17B | 1.17B |
| Average Diluted Shares Outstanding | 1.17B | 1.17B | 1.17B | 1.17B | 1.17B |
| Dividend Per Share | 1.54 | 1.54 | 1.54 | 1.28 | 1.28 |
| Payout Ratio | 66.57% | 56.43% | 64.37% | 52.57% | 65.65% |